Position
Fidelity in Century Therapeutics, Inc.
Back to the book · All holders of IPSC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.67K$2.26 → $2.45
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 71.5K | $71.2K | — | — | — | 0.0% |
| Q1 2026 | 8.78K | $19.8K | $2.26 | $11.1K | −$62.4K | 0.0% |
| Q2 2026 | 8.99K | $22K | $2.45 | $1.67K | $527 | 0.0% |